Search Results - "Ormont, Michael L."

Oxidative stress and lipid retention in vascular grafts : Comparison between venous and arterial conduits by YI SHI, PATEL, Sachin, DAVENPECK, Kelly L, NICULESCU, Rodica, RODRIGUEZ, Evelio, MAGNO, Michael G, ORMONT, Michael L, MANNION, John D, ZALEWSKI, Andrew

“…Because saphenous vein grafts (SVGs) exhibit greater cellular heterogeneity and worse clinical outcomes than arterial grafts (AGs), we examined oxidative…”
Get full text

The role of preoperative radial artery ultrasound and digital plethysmography prior to coronary artery bypass grafting by Rodriguez, Evelio, Ormont, Michael L., Lambert, Erica H., Needleman, Laurence, Halpern, Ethan J., Diehl, James T., Edie, Richard N., Mannion, John D.

“…Objective: Doppler ultrasound and digital plethysmography are used at our institution to determine the suitability of the radial artery for harvest prior to…”
Get full text

Early Injury to the Media After Saphenous Vein Grafting by O’Brien, James E., Ormont, Michael L., Shi, Yi, Wang, Dian, Zalewski, Andrew, Mannion, John D.

“…Background. Injury to the smooth muscle cells of the media affects the remodeling process of vein grafts. The purpose of this study was to determine whether…”
Get full text

Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts by Mannion, John D, Ormont, Michael L, Magno, Michael G, O’Brien, James E, Shi, Yi, Zalewski, Andrew

“…Background. Treatment of saphenous veins with c-myc antisense oligomers during preparation for grafting reduces medial cellular proliferation and macrophage…”
Get full text

Saphenous vein graft protection: Effects of c- myc antisense by Mannion, John D., Ormont, Michael L., Shi, Yi, O'Brien, James E., Chung, Wooksung, Roqué, Fernando, Zalewski, Andrew

“…Objective: Saphenous vein grafting is associated with extensive medial remodeling, characterized by cellular proliferation, loss of smooth muscle cells, and an…”
Get full text

Safety of intracoronary administration of c-myc antisense oligomers after percutaneous transluminal coronary angioplasty (PTCA) by Roqué, F, Mon, G, Belardi, J, Rodriguez, A, Grinfeld, L, Long, R, Grossman, S, Malcolm, A, Zon, G, Ormont, M L, Fischman, D L, Shi, Y, Zalewski, A

“…We wished to assess the clinical safety and pharmacokinetics of ascending doses of a synthetic oligodeoxynucleotide (LR-3280) administered after coronary…”
Get more information